PTENtumor suppressor plays less prognostic role thanP53tumor suppressor in diffuse large B-cell lymphoma (Q42921293)

11 November 2017

title

PTEN tumor suppressor plays less prognostic role than P53 tumor suppressor in diffuse large B-cell lymphoma (English)

1 reference

11 November 2017

PTENtumor suppressor plays less prognostic role thanP53tumor suppressor in diffuse large B-cell lymphoma (English)

1 reference

https://api.crossref.org/works/10.3109/10428194.2010.502584

4 July 2024

author name string

Yan-Yan Liu

1

1 reference

11 November 2017

Shu-Na Yao

2

1 reference

11 November 2017

Yan Zhao

3

1 reference

11 November 2017

Zhi-Hua Yao

4

1 reference

11 November 2017

Jie Ma

5

1 reference

11 November 2017

Qing-Xin Xia

6

1 reference

11 November 2017

Kai Fu

7

1 reference

11 November 2017

Shu-Jun Yang

8

1 reference

11 November 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20807096

4 July 2024

publication date

1 September 2010

1 reference

full work available at URL

11 November 2017

http://www.tandfonline.com/doi/pdf/10.3109/10428194.2010.502584

1 reference

https://api.crossref.org/works/10.3109/10428194.2010.502584

4 July 2024

1 reference

11 November 2017

volume

51

1 reference

11 November 2017

issue

9

1 reference

11 November 2017

page(s)

1692-1698

1 reference

Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

21 January 2018

Surfing the p53 network

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

The multiple roles of PTEN in tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

PTEN: a new guardian of the genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

The role of PTEN signaling perturbations in cancer and in targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Loss of tumor suppressor p53 decreases PTEN expression and enhances signaling pathways leading to activation of activator protein 1 and nuclear factor kappaB induced by UV radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Inactivation of p53 and Pten promotes invasive bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

P53 is a tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Structural profiles of TP53 gene mutations predict clinical outcome in diffuse large B-cell lymphoma: an international collaborative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Analysis of the PI-3-Kinase-PTEN-AKT pathway in human lymphoma and leukemia using a cell line microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Protein expression and cellular localization in two prognostic subgroups of diffuse large B-cell lymphoma: higher expression of ZAP70 and PKC-beta II in the non-germinal center group and poor survival in patients deficient in nuclear PTEN.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Genetic and phenotypic heterogeneity in the PTEN hamartoma tumour syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Methylation of the PTEN promoter defines low-grade gliomas and secondary glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Phosphorylation keeps PTEN phosphatase closed for business

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Mutational analysis of the PTEN/MMAC1 gene in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Critical roles of Pten in B cell homeostasis and immunoglobulin class switch recombination.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Advances in the biology and therapy of diffuse large B-cell lymphoma: moving toward a molecularly targeted approach

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Cancer-derived p53 mutants suppress p53-target gene expression--potential mechanism for gain of function of mutant p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428194.2010.502584

New approach to classifying non-Hodgkin's lymphomas: clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project

21 January 2018

1

1 reference

https://api.crossref.org/works/10.3109/10428194.2010.502584

PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma

4 July 2024

21

1 reference

https://api.crossref.org/works/10.3109/10428194.2010.502584

4 July 2024

Identifiers

1 reference

11 November 2017

1 reference